- CareTech Human is a cutting-edge biotech company at the forefront of disease detection and patient evaluation.
- The company develops advanced devices that enable fast analysis, aiming to identify diseases and assess patient conditions before symptoms emerge.
- By prioritizing early detection, CareTech Human strives to revolutionize healthcare outcomes and enhance patient care.
Early detection of diseases plays a vital role in the prognosis of a disease. Identifying health issues long before they manifest in the form of noticeable symptoms can significantly influence how effective treatment can be provided to the patients.
Many advancements in biotechnology have successfully paved the way for innovative solutions that can detect the presence of diseases well before they settle in and at earlier stages of the disease.
This early detection is helpful to the patients and healthcare providers so that it enables them to effectively optimize the resources available at hand on time.
To this landscape, CareTech Human places itself as a viable candidate to drive the healthcare sector by helping to detect diseases long before any defining symptoms appear.
The Transformative Approach to Healthcare
As early detection of diseases before they become symptomatic can prove to be exponentially effective in the prognosis, CareTech Human is built on the mission to steer this idea to help the patient at an earlier stage.
The company has created a toilet-integrated remote patient health monitoring device designed to monitor lower urinary tract symptoms and detect early signs of urological diseases.
This enables healthcare professionals to make well-informed decisions and implement timely interventions that would prove to be effective in a diagnosis.
Founded by Dan Matsui, a renowned expert in the niche of biotechnology, this US-based biotech company is driven to enhance patient care through superior technologies and innovative solutions.
"CareTech Human empowers people with an innovative, fully automated, painless and affordable toilet-integrated solution for daily health checks and early disease detection." Dr Matsui remarks.
With a streamlined, unobtrusive, and effective system of detection, CareTech Human simplifies procedures with user-friendly technology.
It instantly quantifies symptom severity and streamlines patient assessments. Delivering precise health metrics for accurate condition evaluation also enhances adherence with non-invasive and automated monitoring.
Contactless Sensor for Reliable Measurements
The CareTech unit employs a set of advanced sensors and artificial intelligence designed to collect voiding behavioral data and perform urine molecular analyses.
This data, subsequently uploaded in an encrypted cloud-based machine-learning environment, undergoes thorough analysis.
Summary information is passed to the supervising doctor’s dashboard, which displays a bladder diary, voiding parameters, urgency score, and automated quasi-IPSS score.
Incoming information is automatically prioritized and alerts are issued as appropriate.
As dedicated entrepreneurs, the team at CareTech Human realizes that optical sensing technology, microchips, and cloud processing have progressed to a point where they could revolutionize remote urinalysis.
Developed and launched in Ukraine, and now incubated at and supported by Cornell University, CareTech is dedicated to solving one of the most vexing challenges facing urologists–how to properly monitor and assess patient condition without frequent office visits.
Prospective Shifts for CareTech Human
CareTech Human is poised to make a lasting impact on the healthcare industry through its innovative devices designed for early disease detection and patient evaluation.
The company has received a total of $29 million in funding across 2 rounds as a venture capital-backed company.
With a focus on rapid analysis, comprehensive health assessments, and user-friendly technology, the company is revolutionizing disease management and patient care.
Under such visionary leadership, CareTech Human continues to push the boundaries of biotechnology, offering hope for better health outcomes and improved quality of life for patients worldwide.
Edited By Annette George
